fda compounding semaglutide crackdown october 2025 Intensifies on GLP-1 Semaglutide

Some dispensaries have noted how these medications reduce classic cannabis-related appetite or the munchies. Recent research revealed that metabolic disease and addiction share overlapping biology

GLP-1 RAs are known to help decrease body weight, in part due to decrease in appetite, Aroda told us

Semaglutide slows stomach emptying and alters gut motility, which can cause loose stools even after extended use

Patients interested in exploring whether GLP-1 therapy might complement their overall wellness planincluding addiction supportshould disclose their full substance use history to their healthcare provider

Protein: Maintain Muscle While Losing Weight With reduced calorie intake, protein becomes even more important

Zepbound is currently FDA-approved for the treatment of moderate to severe OSA in adults who: Its not intended for people with mild OSA or those who already manage their sleep apnea successfully through CPAP or other devices